Aberrations of PTPRD were identified to implicate in chronic lymphocytic leukemia,61 and PTPRD was demonstrated as the tumor suppressor in hepatocellular carcinoma by regulating the PD‐1/PD‐L1 axis.62 This evidence concerns the gene CD274 and hepatocellular carcinoma.